{"id":240684,"date":"2026-07-11T23:03:56","date_gmt":"2026-07-12T04:03:56","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/dr-david-sinclair-the-first-human-trial-of-an-age-reversal-therapy-podcast-lifespan-longevity"},"modified":"2026-07-11T23:03:56","modified_gmt":"2026-07-12T04:03:56","slug":"dr-david-sinclair-the-first-human-trial-of-an-age-reversal-therapy-podcast-lifespan-longevity","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/dr-david-sinclair-the-first-human-trial-of-an-age-reversal-therapy-podcast-lifespan-longevity","title":{"rendered":"Dr. David Sinclair: The First Human Trial of an Age-Reversal Therapy #podcast #lifespan #longevity"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/m4umwimC2gg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Harvard geneticist David Sinclair returns to explain how his lab\u2019s age-reversal technology has moved from mice and primates into FDA-cleared human trials \u2014 starting with an attempt to reverse vision loss from glaucoma, a condition considered permanent. Sinclair breaks down the science of Yamanaka factors, why using three genes instead of four sidesteps the cancer risk, and his core thesis: make the body young enough and it can cure its own diseases.<\/p>\n<p>He and James also go deep on the practical longevity playbook: NMN, NAD and Sirtuins, metformin and berberine, testosterone and muscle mass, sleep, diet, and how to separate real science from longevity misinformation. Sinclair shares his own protocol at 56, his 86-year-old father\u2019s results, and teases a next-generation \\.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Harvard geneticist David Sinclair returns to explain how his lab\u2019s age-reversal technology has moved from mice and primates into FDA-cleared human trials \u2014 starting with an attempt to reverse vision loss from glaucoma, a condition considered permanent. Sinclair breaks down the science of Yamanaka factors, why using three genes instead of four sidesteps the cancer [\u2026]<\/p>\n","protected":false},"author":746,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,269],"tags":[],"class_list":["post-240684","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/746"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=240684"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240684\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=240684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=240684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=240684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}